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ABSTRACT 
Objective: To study the diagnostic process, clinical course, and 
outcome of Rwandan refugees with meningococca.l meningi- 
tis, treated in an Israeli field hospital in Goma, Zaire, in the sum- 
mer of 1994. 
Methods: Patient hospital charts and laboratory records were 
reviewed with critical evaluation of clinical presentation and 
diagnostic tests. Patients were treated as part of a disaster 
relief effort in a refugee camp experiencing several coexisting 
lethal epidemics. 
Results: A total of 65 patients were identified as having group 
A meningococcal meningitis. Latex agglutination test for IVeis- 
seria meningifidis soluble antigen in the cerebrospinal fluid was 
found to be a superior diagnostic tool, as compared to Gram 
stain, and at least as effective as culture. The mortality rate 
was 14%; mortality was markedly affected by co-morbidity 
(e.g., dysentery, pneumonia, and malnutrition). 
Conclusions: The outcome of patients with meningococcal 
meningitis, treated in referral centers within a disaster area may 
be favorable, despite overwhelming coexisting epidlemics, and 
may be comparable to that achieved in advanced medical facil- 
ities Encephalopathy may be a diagnostic pitfall in the per- 
spective of coexisting epidemics, requiring a high index of 
suspicion and routine lumbar puncture. The latex agglutination 
test is highly useful in achieving prompt diagnosis elf meningo- 
coccal meningitis, in particular when sample handling for cul- 
ture and microscopy is suboptimal. 
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Epidemic meningococcal disease has been a feature of 
sub-Saharan Africa for over a century. Major epidemics 
of group A Neisseria meningitidis, caused in particular 
by clone III-l, spread over the last decades from China to 
the sub-Saharan “meningitis belt.“le5 They were controlled 
only after nonselective immunization of the population 
in affected areas with polyvalent vaccine against N: 
meningitidis group A and C.6,7 
Tribal war in Rwanda during June and July 1994 
resulted in a major medical disaster, with over 100,000 
refugees dying within a few weeks at the Rwanda-Zaire 
border, north of Lake Kivu. Manslaughter, cholera, and 
bacillary dysentery were the initial and leading lethal epi- 
demics, followed chronologically by malnutrition, menin- 
gitis, and malaria.*,” 
Over 65 patients with meningococcal meningitis 
were relocated for treatment to the Israeli Army Field 
Hospital in Goma, Zaire. This communication summarizes 
their medical course and proposes guidelines for the diag- 
nosis and management of such patients in disaster areas. 
MATERIAL AND METHODS 
During July and August 1994,360O patients were treated 
by the Israeli Relief Mission. The hospital served as the 
first echelon for patients (most of whom presented with 
a cholera-like illness) from nearby refugee camps during 
the frost 2 weeks, then was converted, over the next 4 
weeks, into a referral medical facility, backing up primary- 
care facilities and cholera camps, under the coordination 
of the United Nations High Commissioner for Refugees 
(UNHCR).” During this period an outbreak of meningo- 
coccal meningitis occurred almost simultaneously in sev- 
eral refugee camps, but was most striking in Kibumba. A 
substantial fraction of these patients were referred to the 
Israeli field hospitaLs or were transported by a mobile 
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team of the hospital from primary care facilities within 
the camps. 
In the triage tent of the hospital a lumbar puncture 
was done routinely on all suspected cases, and a Gram 
stain was performed at the hospital’s laboratory. In most 
cases, duplicate samples of cerebrospinal fluid (CSF) were 
sent to the microbiology laboratory of the French Army 
Medical Corps (Bioforce) who were encamped at the 
Goma airport. Lumbar puncture was not repeated in 
referred partially treated patients, as their diagnosis was 
established at the first medical echelon by the clinical 
presentation and a turbid CSE Some CSF samples from the 
latter patients also reached the French laboratory 
An isolation tent for meningitis was constructed; it 
was divided into pediatric and adult sections. It was run 
by a nurse and one or two corpsmen/paramedics during 
day shifts, and one corpsman/paramedic at night. Patients 
were attended by an internist or pediatrician, guided by 
a specialist in infectious diseases. Patients remained in 
this unit until convalescence and discharge from the hos- 
pital, with occasional exceptions who required further 
treatment or rehabilitation and who were moved to other 
wards for the rest of their hospital course. 
At the Bioforce laboratory, CSF samples were ana- 
lyzed by Gram stain and by latex agglutination test for the 
presence of A? meningitidis soluble antigens (Pastorex 
A/B/C, SANOFI Diagnostics Pasteur, France). Cerebrospinal 
fluid samples were cultured using standard procedures. 
Subgroup classification of N meningitidis cultures was 
determined using a latex agglutination test (SANOFI Diag- 
nostics Pasteur). 
The authors retrospectively analyzed the clinical 
course and outcome of patients with meningococcal 
meningitis, using the patients’ hospital files and records 
of the French Army microbiology laboratory. Although 
the Israeli field hospital was run by three successive 
teams, each operating for 2 weeks, the medical archive of 
only the first two teams was available for analysis. The 
medical records of the last team were lost during trans- 
port. Of 2525 patients treated by the first two teams 
(between July 26 and August 22, 1994) 2146 medical 
records (85%) were available for analysis. The diagnosis 
of meningococcal meningitis in this type A epidemic was 
based on: (A) positive CSF Gram stain for gram-negative 
diplococci, or positive culture or positive latex aggluti- 
nation test for soluble antigen (definitive diagnosis); or (.B) 
a clinical picture compatible with bacterial meningitis, 
associated with the presence of turbid CSF; or (C) a clin- 
ical picture compatible with meningitis and documented 
incomplete treatment for suspected meningococcal 
meningitis at the frst medical echelon.8 Sixty-five patients 
fulfilling these inclusion criteria were identified (43, 13, 
and 9 patients belonging to categories A, B, and C, respec- 
tively) and most of their demographic data, clinical 
course, and laboratory findings were retrieved. The med- 
ical records of 16 convalescing patients, admitted during 
the final week of the second medical team were among 
the records lost during transportation, but their laboratory 
data were accessible. 
Data were evaluated with a statistics program 
(Crunch Software Corporation, USA). Values are presented 
as means ? SEM. Descriptive statistics, simple correla- 
tion, multiple regression analysis, Student’s t-test, and Pear- 
son chi-square analysis were applied as detailed below, 
with statistical significance set at P < 0.05. Since some 
variables were often missing, the numbers of patients 
with available data for each variable detailed below 
appear in parentheses. 
RESULTS 
Demographic Features 
Demographic and clinical data of the 65 patients with 
meningococcal meningitis are summarized in Table 1. 
Their mean age (13.4 2 1.4 years) was younger than that 
of the unselected hospitalized population (18.4 2 0.4 
years, n = 1986, P < 0.05). Half of the patients were 10 
years old or less, the youngest being 1 week old. Patient 
admissions data, stratified chronologically according to 
the day of admission and the source refugee camp, are 
presented in Figure 1. Two distinct clusters of cases were 
noted: the first, consisting of patients from Muginga 
refugee camp, lasted from day 7 through day 20 and 
peaked at day 14. The second, comprised of patients arriv- 
ing simultaneously from Kibumba camp and from the 
district of Goma, started on day 15, peaked on day 2 1, and 
declined afterward, perhaps as the result of a vaccination 
project in Kibumba.9 
On the average, admission occurred within 1.5 days 
after the beginning of symptoms. Delay in admission 
occurred in 10 of 32 patients, and was often related to 
earlier diagnosis and treatment in the first echelon. Two 
of these patients were treated with long-acting chloram- 
phenicol intramuscular injections at the referring medical 
facility.7,11~1z One patient was treated with penicillin and 
three others received other antibiotics. Four patients were 
misdiagnosed before admission and treated for malaria, 
with quinine. 
Clinical Data 
Fever was present in all patients (n = 30), signs of 
meningeal irritation in 94% of 36 patients (27 with nuchal 
rigidity and 7 with opisthotonos), and altered con- 
sciousness in 51% of 35 patients (7 with somnolence, 8 
with stupor, and 3 in deep coma). Six of 36 (17%) pre- 
sented with generalized convulsions on admission or dur- 
ing hospitalization, and one patient arrived in profound 
shock. Two patients presented with concomitant extra- 
meningeal infection (one with monoarthritis of the knee, 
and another with purulent keratoconjunctivitis). None of 
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Table 1. Demographic Data and Clinical Features in 65 Patients with Meningococcal Meningitis 
Variable Value6 
Age (yr) (n = 53*) 13.3 i 1.4 
Remarks 
Mean age of unselected hospitalized patients was 
Sex (males/females) (n = 52*) 
Refugee camp (n = 53*) 
Prehospitalization period (d) (n = 23*) 
Hospitalization period (d) (n = 46*) 
Co-morbidity (n = 36*) 
Clinical features (n = 30-36*) 
Diagnosis (n = 42-56*) 
Treatment (n = 37*) 





1.5 * 0.2 














































7 with opisthotonos 
7 with somnolence; 8 with stupor, and 3 in deep coma 








*Number of documented observations; imean ? SEM; *ciprofloxacin given alone due to early misdiagnosis (see text): C = chloramphenicol; P = penicillin. 
the patients presented with the clinical syndrome of 
meningococcemia. 
Three patients with non-meningococcal bacterial 
meningitis were excluded from this series: two succumbed 
to gram-negative meningitis (Escherichia coli and Enter- 
obacter sp.), complicating advanced bacillary dysentery 
m Kibumba 






Figure 1. Chronologic distribution of 65 patients with meningococ- 
cal meningitis, also stratified according to the refugee camps from 
which they came. Date refers to the day of patients’ admission. The 
airborne field hospital landed at Goma, Zaire, on July 25, 1994, (day 
0) and the first patients were admitted within 24 hours of arrival. 
with septicemia, and an additional patient presented with 
meningitis and a huge cervical abscess. Turbid CSF in this 
case was not further evaluated to identify the causative 
organism, and the patient recovered on empirical therapy 
of chloramphenicol, penicillin, gentamicin, and cefazolin. 
Information on coexisting diseases was available in 
11 of 36 patients (3 1%): three had cholera-like illness and 
six had bacillary dysentery. Pneumonia, malaria due to 
Plasmodium falciparum, and advanced malnutrition 
were diagnosed in each of three patients. As previously 
reported, l3 17 patients with meningococcal meningitis 
were tested for human immunodeficiency virus (HIV) 
infection. Two (12%) were found to be HIV-l seropositive, 
as compared to 33 of 110 unselected patients without 
meningitis (30%). 
Diagnostic Yield 
Cerebrospinal fluid samples from 42 patients were 
processed at the Bioforce reference laboratories; CSF 
specimens from an additional 14 patients were processed 
only at the field hospital’s laboratory. Altogether, CSF was 
reported to be turbid in 45 of 56 samples (SO%), bloody 
in 7 of 56 (13%) and clear in 4 of 56 (7%). Gram stain 
showed gram-negative diplococci in 31 of 43 patients 
(72%). Latex agglutination tests for soluble antigens were 
positive in 41 of 42 CSF samples @So/,>, all were serotype 
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Table 2. Cerebrospinal Fluid Analysis* 
Number of Turbid or Gram Latex 
Specimens Bloody CSF Stain Culture Agglufinafion 
(n = 30) (n = 41) 
(71%) (98%) 
28 + + + + 
7 + + + 
1 + + + 
1 + + - 
1 + - + 
1 - + + + 
1 + + 
2 - - + 
*Diagnostic yield of CSF appearance, Gram stain (gram-negative diplococci), 
culture (Neisseria meningikLs), and latex agglutination test for soluble antigen of 
Neisseria meningifidis group A in 42 CSF samples of patients diagnosed as 
having meningococcal meningitis and evaluated at the Bioforce reference 
laboratory Additional 24 processed CSF samples from the Israeli hospital did 
not meet any of the inclusion diagnostic criteria: 22 were negative by all 
parameters and 2 turbid samples grew gram-negative bacilli, that were also 
identified by direct Gram stain and were negative by the latex agglutination test 
(true negative). 
A. Neisseria meningitidis serogroup A was recovered in 
cultures from 38 of the 42 samples (90%). 
Table 2 summarizes the various combinations of find- 
ings at the Bioforce laboratories. Cerebrospinal fluid of 
the two other patients who had gram-negative bacilli visu- 
alized on microscopy yielded E. coli and Enterobacter 
sp. on culture. Latex agglutination for meningococcal sol- 
uble antigens was negative in both patients. Twenty-two 
additional microscopically negative CSF samples (not 
included in this series) also failed to yield a positive agglu- 
tination test for meningococcal soluble antigen or a pos- 
itive culture for meningococci. 
Medical Course and Outcome 
Complete follow-up was available for 45 patients: 37 
(82%) apparently recovered fully, 2 had obvious resid- 
ual neurologic damage (4%) and 6 died (13%). The hos- 
pital course was short, averaging 4.5 days, and was not 
affected by the exclusion of patients who died. A com- 
bination of parenteral antibiotic therapy with penicillin 
(4.0 million U 6 times a day; pediatric dose: 150,000- 
250,000 U/kg/day) and chloramphenicol (1.0 g 4 times 
a day; pediatric dose: 100 mg/kg/day) was used as the 
initial therapy in 78% of patients (29/37). Of those receiv- 
ing this combination, the mortality rate was low (7%), 
whereas of the seven others treated with chlorampheni- 
co1 alone (n = 6) or penicillin alone (n = l), two died 
(29%, one receiving chloramphenicol and the other peni- 
cillin alone). One additional patient with meningococcal 
meningitis was admitted with what appeared to be clin- 
ical dysentery, altered mentation, and profound shock. He 
was initially treated with parenteral ciprofloxacin, and 
died within hours after arrival, shortly after lumbar punc- 
ture was performed. 
Mortality correlated with the presence of co-mor- 
bidities, including dysentery, pneumonia, or severe mal- 
nutrition (r = 0.54, P < 0.001) and with the presence of 
encephalitic features (r = 0.53, P < 0.02). It correlated 
inversely with combination antibiotic therapy (r = 0.6, P 
< 0.006) but the different outcome between patients on 
one versus two antibiotics failed to reach statistical sig- 
nificance (Pearson chi-square analysis, P = 0.16). Mortal- 
ity rates were comparable among the three inclusion 
categories and were not affected by prehospitalization 
course, sex, age, the presence of generalized convulsions, 
or various CSF findings. Regression analysis determined 
that co-morbidities significantly affected the outcome 
(B-0.51, Beta 0.34, F-to-remove 4.7, P = 0.037) with the 
impact of treatment modality on mortality falling short of 
statistical significance (B-0.37, Beta 0.28, F-to-remove 3.7, 
P = 0.064). 
DISCUSSION 
This report presents an analysis of the clinical presentation 
and hospital courses of 65 patients with meningococcal 
meningitis; it is compromised by its retrospective nature 
and by incomplete documentation. Nevertheless, it pro- 
vides a unique view of medical care of a highly conta- 
gious and lethal infection in a disaster area where medical 
facilities were limited and directed mainly at providing 
mass treatments. Though these conditions may not be 
optimal for individual patient care, this study shows that 
it may be possible, even in a disaster relief setting, to 
achieve rates of success in treating meningococcal menin- 
gitis that are comparable to those in advanced medical 
facilities and at referral centers attending meningococcal 
epidemics. 3,14-20 In fact, the overall mortality in this series 
may have been as low as lo%, had we considered as 
cured the 16 convalescing patients, for whom no final 
outcome information was available. 
Most patients (94%) with meningococcal meningitis 
presented with meningeal signs, while 48% had altered 
state of consciousness on admission. These figures may be 
somewhat misleading since many patients without typi- 
cal meningeal signs may have succumbed undiagnosed at 
the first medical echelon inside the camps. Impaired con- 
sciousness, which could have resulted from other preva- 
lent causes, such as shigella encephalopathy, cerebral 
malaria, nutritional deficiencies, and electrolyte abnor- 
malities, was a source of diagnostic pitfalls, especially if 
unaccompanied by meningeal signs. Thus, four patients 
with meningococcal meningitis were erroneously treated 
in the frost medical echelon for cerebral malaria, and a 
fifth one, presenting at the triage unit only with enceph- 
alopathy and bloody diarrhea was given ciprofloxacin for 
presumed shigella dysentery. 
All patients included in this series underwent lumbar 
puncture, either at the first echelon or at the authors’ 
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facility. The importance of this simple bedside procedure 
cannot be overemphasized, even in an epidemic setting 
in a disaster area. This procedure seemed especially impor- 
tant in patients with altered mentation in the abeence of 
meningeal signs, as observed in 6% of meningitis cases as 
well as in 2% of I068 refugees who presented with clin- 
ical dysentery (Unpublished data). Additionally, experience 
suggests that turbid CSF may not suffice for the appro- 
priate antibiotic management of patients during an epi- 
demic of meningococcal meningitis, especially in settings 
of parallel epidemics. A more definitive diagnostic pro- 
cedure seemed warranted. This is well illustrated by the 
two patients with culture-proven gram-negative bacillary 
meningitis complicating dysentery (3% of all patients with 
bacterial meningitis), or by the patient with meningitis 
and a huge cervical abscess, treated with four antibiotics 
for an undiagnosed pathogen. 
In this study it was possible to compare the diag- 
nostic yield of a CSF Gram stain, culture, and the latex 
agglutination kit for the detection of soluble Imeningo- 
coccal antigen. This evaluation was limited, however, since 
a gold standard has not been defined to establish the diag- 
nosis: patients were considered as having a definite 
meningococcal meningitis (category A), if any of the three 
diagnostic tests was positive. Thus, the specificity and the 
predictive values of these tests could not be assessed (for 
instance, one could argue that the single case of positive 
latex agglutination test and negative Gram stain and cul- 
ture is a false positive). With this limitation in mind, how- 
ever, if all positive findings are considered as true positives, 
the latex agglutination test seems to be superior for the 
diagnosis of meningococcal meningitis (98% sensitivity), 
as compared to Gram stain (71%) or culture @O%).The test 
was negative in all 22 normal CSF samples and in the two 
patients with Gram negative meningitis (100% specificity). 
This is comparable with previous observations,19.21 and 
underscores an advantage of the agglutination technique 
under the circumstances, where sample handling was not 
optimal: CSF was often processed long after it was 
obtained, after being kept in a refrigerator for up to 24 
hours before delivery to Bioforce laboratories. Such a delay 
could have resulted in a reduced efficacy of culture and 
microscopic evaluation. Since culture requires more time 
and equipment, it seems that under disaster conditions 
the CSF appearance, Gram stain, and latex agglutination 
will suffice for diagnosis of most cases of meningococcal 
meningitis. The latex agglutination test may even substi- 
tute for microscopy during a meningococcal epidemic,’ 
with Gram stain and CSF culture reserved for selected 
patients (e.g., typical clinical features or turbid CSF and 
negative latex agglutination). 
The impact of other co-morbidities, such as dysen- 
tery, pneumonia, or malnutrition upon patients’ outcome 
was remarkable. To the authors’ knowledge, these prog- 
nostic factors have not been described before in out- 
breaks of meningococcal meningitis. The lower incidence 
of HIV infection among patients with meningococcal 
meningitis is probably the result of their younger age, as 
compared to the unselected population treated in the 
authors’ facilities. 
The efficacy of the combined chloramphenicol-peni- 
cillin regimen for meningococcal meningitis was high 
(7% mortality), comparable to that achieved in most 
advanced medical facilities. The use of chloramphenicol 
(n = 6) or penicillin (n = 1) alone was associated with a 
higher mortality rate of 29%, but the numbers were too 
small for statistical significance. Though penicillin is cur- 
rently considered the drug of choice,22 intramuscular 
injection of chloramphenicol has been suggested as the 
first-line treatment for meningococcal infection in epi- 
demics in disaster settings.“~‘2~23 Other groups have 
reported what appeared to be a relatively poor efficacy 
of this monotherapy. Some of these patients died, await- 
ing transportation. 
Interestingly, all 20 evaluable patients from Kibumba 
camp survived, as compared to 19 of 25 patients from 
other camps (76%). This may reflect a selection bias, since 
Kibumba was the refugee camp most remote from Goma, 
and some patients referred to the authors’ facility from 
that camp were given initial treatment at the primary 
care facility, whereas others died before treatment and 
transportation were available. This is in contrast to 
patients arriving directly from refugee camps closer to 
the field hospital, without a delay for diagnosis or pre- 
treatment at a primary care facility. 
The favorable outcome of the authors’ patients 
occurred despite the fact that corpsmen provided most 
of the nursing care. Under meticulous supervision and 
instruction by the head nurse, they quickly mastered the 
numerous preparations and frequent intravenous admin- 
istrations required for the combined penicillin and chlo- 
ramphenicol regimen. Under these circumstances, single 
daily intramuscular injections of ceftriaxone would have 
been more convenient. Incorporation of physicians, expe- 
rienced in disaster medicine and in infectious diseases, 
within the framework of the military mission provided 
the ability to “specialize” in complex medical conditions, 
such as bacterial meningitis. Referral medical facilities 
have a role in these types in disaster areas, to supplement 
and back up primary care medical systems that lack the 
capacity to address such medical problems. 
In conclusion, in the midst of epidemics of meningo- 
coccal meningitis, cholera, and dysentery, the recovery 
rate from meningitis among Rwandan refugees was com- 
parable to that achieved in advanced medical facilities. 
Cure rates were influenced by co-morbidities, such as 
shigellosis, pneumonia, and malnutrition. Encephalopathy 
without meningeal signs was a diagnostic pitfall, in the 
perspective of coexisting epidemics. This required a high 
index of suspicion and routine lumbar puncture in such 
patients. The latex agglutination test for soluble antigen in 
the CSF was highly useful in achieving prompt diagnosis 
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of meningococcal meningitis, in particular when sample 
handling for culture and microscopy was suboptimal. The 
combined regimen of chlommphenicol and penicillin was 
effective, achieving a high cure rate. Finally, relief teams 
operating referral centers within the disaster area may 
back up primary care facilities, by specializing in complex 
medical conditions, such as meningococcal meningitis. 
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